What Is Bicatero 50 (Bicalutamide Tablets IP 50mg)?
Bicatero 50 is a prescription anticancer medicine containing Bicalutamide 50 mg, a non-steroidal antiandrogen primarily used in the treatment of advanced prostate cancer.
Prostate cancer is a disease in which abnormal cells develop in the prostate gland. Many prostate cancers depend on male hormones called androgens, particularly testosterone and dihydrotestosterone (DHT), for their growth and survival.
Bicalutamide works by blocking androgen receptors in prostate cancer cells, reducing the ability of male hormones to stimulate cancer growth.
Bicatero 50 is commonly prescribed as part of combined androgen blockade, where bicalutamide is administered alongside treatments that reduce testosterone production, such as luteinizing hormone-releasing hormone (LHRH/GnRH) agonists or surgical castration.
The medicine does not directly lower testosterone production. Instead, it prevents androgens from activating their receptors in target tissues.
Bicatero 50 may be used as part of treatment for:
- Advanced prostate cancer
- Metastatic prostate cancer
- Hormone-sensitive prostate cancer requiring combined androgen blockade
- Prostate cancer managed with medical or surgical castration
- Selected patients beginning GnRH agonist treatment to reduce the effects of testosterone flare
Treatment decisions depend on cancer stage, previous therapies, hormone sensitivity, general health, and specialist assessment.
Important: Bicatero 50 is not a permanent cure for prostate cancer. It is a prescription hormonal anticancer medicine that must be used under the supervision of an oncology or urology specialist.
How Does Bicatero 50 Work?
1. Blocks Androgen Receptors
Bicalutamide is a non-steroidal antiandrogen that binds to androgen receptors.
It prevents testosterone and dihydrotestosterone from activating these receptors in prostate cancer cells.
2. Reduces Androgen-Driven Cancer Signaling
Many prostate cancer cells rely on androgen receptor signaling for growth and survival.
By blocking this signaling, bicalutamide helps inhibit hormone-dependent cancer activity.
3. Supports Combined Androgen Blockade
Bicalutamide 50 mg is commonly used with treatments that suppress testosterone production.
The combination reduces circulating androgen stimulation and blocks remaining androgen receptor activity.
4. Helps Manage Advanced Prostate Cancer
Bicalutamide may help slow progression of androgen-sensitive prostate cancer when used as part of an appropriate treatment regimen.
5. Reduces the Effects of Testosterone Flare
Some GnRH agonist treatments initially cause a temporary increase in testosterone.
Bicalutamide may be prescribed around treatment initiation to reduce certain clinical effects of this hormone surge.
6. Acts Without Directly Suppressing Testosterone Production
Unlike GnRH agonists or antagonists, bicalutamide primarily blocks androgen receptors rather than directly reducing testosterone production.
7. Provides Oral Antiandrogen Treatment
Bicalutamide is administered orally, allowing it to be incorporated into a specialist-directed prostate cancer treatment plan.
Uses of Bicatero 50 (Bicalutamide 50 mg)
1. Advanced Prostate Cancer
Bicatero 50 is used as part of hormonal treatment for advanced prostate cancer.
2. Metastatic Prostate Cancer
Bicalutamide 50 mg may be prescribed with androgen deprivation therapy for metastatic prostate cancer when clinically appropriate.
3. Combined Androgen Blockade
Bicalutamide may be combined with medical or surgical castration to reduce androgen receptor signaling.
4. Hormone-Sensitive Prostate Cancer
It may be used in selected patients whose prostate cancer remains responsive to hormonal treatment.
5. Treatment Alongside GnRH Agonists
Bicalutamide may be prescribed with GnRH agonists such as leuprolide or goserelin.
6. Management of Testosterone Flare
It may help reduce certain effects of the temporary testosterone increase that can occur when starting GnRH agonist therapy.
7. Prostate Cancer Symptom Management
When cancer responds to treatment, hormonal therapy may help improve certain disease-related symptoms.
However, symptom improvement is not guaranteed.
8. Individualized Oncology Treatment
Bicalutamide may be included in a broader treatment plan involving other hormonal medicines, radiotherapy, or additional cancer treatments when clinically appropriate.
Important: Bicalutamide 50 mg should not be assumed to be effective or approved as standalone treatment for all stages of prostate cancer. Modern treatment choices depend on disease stage and current oncology guidelines.
How to Take Bicatero 50
Bicatero 50 should be taken exactly as prescribed by an oncology or urology specialist.
Step-by-Step Administration Instructions
- Take the medicine according to the prescribed schedule.
- Swallow the tablet with water.
- It may generally be taken with or without food.
- Take it at approximately the same time each day when prescribed for daily use.
- Do not increase or reduce the dose independently.
- Continue any prescribed androgen deprivation treatment.
- Attend scheduled oncology appointments.
- Complete recommended blood tests and monitoring.
- Report unusual symptoms or side effects promptly.
- Do not stop treatment without consulting the prescribing specialist.
Dosage Information
For its established combination-treatment indication, bicalutamide is commonly prescribed at 50 mg once daily with medical or surgical castration.
However, the actual treatment regimen must be determined by the prescribing specialist.
The appropriate treatment depends on:
- Cancer stage
- Hormone sensitivity
- Previous prostate cancer treatments
- Liver function
- Other medical conditions
- Concurrent medications
- Clinical response
- Country-specific prescribing information
Missed Dose
If a dose is missed, follow the instructions provided by the prescribing healthcare professional or product leaflet.
Do not take a double dose to compensate for a missed tablet.
Important Administration Instructions
- Use only under specialist supervision.
- Follow the prescribed dosage.
- Do not independently discontinue treatment.
- Continue associated hormonal therapy as directed.
- Attend regular liver function monitoring.
- Report persistent nausea, jaundice, or unusual fatigue.
- Inform the healthcare professional about all other medicines.
- Do not use the medicine for non-prescribed hormonal purposes.
How Long Does Bicatero 50 Take to Work?
Bicalutamide begins blocking androgen receptors after administration, but its clinical effects on prostate cancer are assessed over time.
Changes in prostate-specific antigen (PSA), disease-related symptoms, and imaging findings may develop over several weeks or longer.
Treatment response depends on:
- Cancer stage
- Hormone sensitivity
- Concurrent androgen deprivation therapy
- Previous treatments
- Overall health
- Individual biological response
The prescribing specialist may monitor PSA levels, testosterone levels when appropriate, clinical symptoms, and imaging results to evaluate treatment effectiveness.
Common Side Effects
Possible side effects include:
- Hot flashes
- Breast tenderness
- Breast enlargement (gynecomastia)
- Nausea
- Constipation
- Diarrhea
- Abdominal discomfort
- Fatigue
- Weakness
- Dizziness
- Reduced sexual desire
- Erectile dysfunction
- Skin rash
- Itching
- Fluid retention
- Anemia
Some adverse effects may also be related to concurrent androgen deprivation therapy.
Serious Side Effects
Seek prompt medical attention if you experience:
- Yellowing of the skin or eyes
- Dark urine
- Severe or persistent abdominal pain
- Unusual or severe fatigue
- Persistent nausea or vomiting
- Severe allergic reactions
- Swelling of the face, lips, or throat
- Unexplained shortness of breath
- New or worsening cough with breathing difficulty
- Unusual bleeding or bruising
Rare but serious complications may include:
- Severe liver injury
- Liver failure
- Interstitial lung disease
- Severe hypersensitivity reactions
- Significant bleeding, particularly with certain anticoagulants
Important: Serious liver injury, including fatal cases, has been reported with bicalutamide. Liver function monitoring is particularly important during the first several months of treatment.
































































